SUMMARY
A therapeutic trial with chiorpromazine was conducted with a homogeneous (for age and sex) group of recently admitted schizophrenic patients. Extrapyramidal effects were measured through quantitative analysis of digital tremor, after four days of fixed-dose treatment.
Assessment of treatment efficacy was based on Brief Psychiatric
Rating Scale ratings, done at the end of four weeks' treatment.
Those patients whose tremor was least affected by drug were most likely to benefit from the treatment.
Implications of this negative correlation for our understanding of the neuroleptic hypo thesis and the closely associated dopamine hypothesis of schizophrenia are discussed. Janssen (1965) . Curvilinearresultswere also reported by Simpson and Kunz-Bartholini (1968) . Curvilinear and null results were reported by Bishop, Gallant and Sykes (1965) . Null results were reported by Karn and Kasper (1959) , Hollister, Caffey and Klett (1960) and Goldman (1961) . A negative correlation between EPSE and therapeutic response was reported by Simpson ci al (1964) . Recent biochemical and pharmacological insights have suggested experimental controls which have not been included in the past. We here report results from a study, utilizing these controls, which indicates that there is a negative correlation between the two classes of neuro leptic action. These observations have implica tions for the neuroleptic hypothesis and the closely associated dopamine hypothesis of schizophrenia (e.g. Meltzer and Stahl, 1976) .
The experimental controls which must be considered have three main areas. Firstly, drug factors: drugs differ in their tendency to provoke EPSE and two independent mech anisms have been identified as influencing them â€"¿ apositive relation with the compound's dopamine receptor blockage potency (Creese, Introduction Delay et al (1955) in the description and classification of EPSE and concluded that a good deal of the ambiguity in the study of neuroleptic hypothesis may be attributable to methodologi cal inadequacies. They urged the use of quanti tative measuring instruments and experimental rigour. Our measure of EPSE is based on a quantitative analysis of digital tremor, recorded bilterally from each index finger (Alpert, Lomask and Friedhoff, 1966) and then analyzed for amplitude and spectrum of the tremor wave form (Alpert, 1975 because of the sensitivity of the system, it is possible for it to detect neuroleptic effects below their threshold for clinical expression.
We have recently reported results from a pilot study, incorporating the methods described above (Alpert, Diamond and Kesselman, 1977) . In this, we studied ten recently admitted premenopausal female schizophrenics treated with fixed doses of trifluoperazine, and found that those patients showing the least tremor changes during the first week of treatment tended to show better responses to treatment three weeks laterâ€"a negative correlation be tween EPSE and treatment outcome. The present study was designed to replicate and extend this previous report. In addition to our tremographic measure of EPSE, we also studied sedation because it is a frequent side effect of antipsychotic compounds and might provide a control for any non-specific tendency of patients to show side-effects. This tendency could, in itsell be related to outcome, so that inclusion of a measure of sedation might serve as a control for the specificity of a relation There was a baseline placebo period of four to seven days, followed by four weeks of chior promazine (CPZ) treatment. Chloral hydrate was permitted during the baseline period.
Starting dose of CPZ was 200 mg/day at bed time. This was increased daily in 200 mg/day increments for five days, always in a single bedtime dose. Two patients developed side effects and were held on 600 mg/day on days four and five. After the dose-range period, medication was adjusted at doctors' choice to attempt to achieve an optimum therapeutic dose. Anticholinergic drugs could be added and five patients received them during the three week adjusted dose period. The average daily dose of CPZ in the last week of treatment was 996 mg.
Tremor was recorded in the morning at base-line and during the week of fixed dose increments. To measure sedative effects, we used a clinical scaleâ€"the Stanford Sleepiness Scale (SSS) (Hoddess, Dement and Zarcone, 1973)â€"and a psychometric measureâ€"the Digit Symbol Substitution Test (DSST) (Wechsler, 1958) . The measure of treatment response was based on the Brief Psychiatric Rating Scale (BPRS) (Overall and Gorham, 1962) . The SSS and DSST were administered following each tremor recording. Two psychiatrists inde pendently rated each patient at base-line and termination of treatment, using the BPRS. BPRS inter-rater reliabilities were above .9 and the two ratings were averaged in the results.
Results
At base-line, the average BPRS total score was 48.0, with a standard deviation of 11.04.
At termination, these figures were 31.9 and 9.33 respectively. The range of changes was from +3 (one patient had a higher BPRS at termination) to â€"¿ 49, and it is the association of this range of therapeutic responses with the measures of side-effects that were examined.
There was a monotonic increase in sleepiness scores over the five dose-increment days, but no suggestion of such a trend for the DSST scores. The two measures of sedation were uncorrelated and were unrelated to either the tremographic measures or the BPRS measures. The sedation results will not be described further here. Fig 1 contains the average tremor spectra .040E
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In previous work, we found that tremor energy in the 2â€"4Hz band is most reflective of EPSE, which appear as a shift of energy into this band, with or without an increase in overall amplitude. To investigate the relationship between the EPSE and therapeutic effects of CPZ, we calculated the correlations between 2â€"4Hz energy and BPRS score. The relation ships to be described hold, at equal confidence levels, for total tremor energy. In Table 1A , the inter-correlations between base-line and termi nation BPRS scores and 2â€"4Hz energy at base line and on day four are presented. Day four tremor will be discussed because it is the highest dose to which most of the patients were uniformly exposed and because on day three, two patients required diphenhydramine be cause of side-effects. The relations to be des cribed hold, in a somewhat weaker form, for days three and five.
In Table lA it can be seen that on day four, 2â€"4Hz energy is positively related to termina tion BRPS; patients who are more affected by neuroleptic on day four tend to do less well at outcome. However, day four 2â€"4Hz tremor is also weakly correlated with the base-line BPRS measure and with the base-line tremor measure.
To partial out the relations among these predictors, a multiple regression analysis was carried out, relating termination BPRS with base-line BPRS, base-line 2â€"4Hz tremor and day-four tremorâ€"with the predictors inserted in that order (Table 1B) . Here it may be seen that base-line BPRS explains only 10 per cent of the outcome variance and that base-line tremor 
B. Summaryofmultiple regression analysis ofdatein (A)
above t P <.05 measures is removed, yielding an F of 8.8 which, with 1/13 df, is significant at P < . 05.
Discussion
Our main findingâ€"that neuroleptic effects are negatively associated with outcomeâ€"is a replication and extension of the report of Simpson et al (1964) and of our earlier study (Alpert, Diamond and Kesselman, 1977) . The null association between sedative side-effects and outcome may reflect measurement difficulties in this area, although neither of our measures was an effective predictor and both are of established reliability.
The predictive efficiency of tremo graphy and the null results for sedation, taken together, suggest that these are relatively specific relations and thus consistent with the neuroleptic hypothesis. The inverse nature of the correlation indicatesthat the findingisnot simply an artifact of drug kinetics, since factors such as drug absorption or metabolism would tend to produce positive correlations between two overlapping processes. Such a mechanism is also consistent with the number of recent reports of improve ment in therapeutic response, following the addition of l-dopa to a regimen of standard neuroleptic treatment of chronic schizophrenics (Alpert et al, 1977) . However, such a mech anism would not be consistent with the reported sensitivity of schizophrenics to methyiphenidate (Janowsky et al, 1973 ) the amphetamine model of paranoid schizophrenia (Angrist et al, 1974) or the report of low MAO in schizophrenics (Wyatt and Murphy, 1976) , all of which implicate hyperdopaminergic states in the pathogenesis.
Nor is it apparent how increased levels of dopamine, either provoked by neuro leptic drugs or via the addition of 1-dopa to neuroleptic drugs, would be therapeutic in the presence of the dopamine blocking drug. How ever, since insights into the mechanism of action of anti-schizophrenic drugs provide such an important source of information about the pathophysiology of schizophrenia, further study of these mechanisms, especially in relation to their temporal course, should prove valuable.
